J & J ’ s One-Shot COVID-19 Vaccine Advances to Phase 3 Testing J & J ’ s One-Shot COVID-19 Vaccine Advances to Phase 3 Testing

Johnson& Johnson has advanced its one-shot COVID-19 vaccine into phase 3 testing. The National Institute of Allergy and Infectious Diseases describes this as the fourth candidate to reach this stage.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Infectious Diseases News Source Type: news